{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:07:23Z","timestamp":1791022043593,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.numecd.2011.10.003","type":"journal-article","created":{"date-parts":[[2011,12,31]],"date-time":"2011-12-31T20:50:31Z","timestamp":1325364631000},"page":"382-388","source":"Crossref","is-referenced-by-count":15,"title":["Soluble receptor for advanced glycation end-product levels are related to albuminuria and arterial stiffness in essential hypertension"],"prefix":"10.1016","volume":"23","author":[{"given":"K.","family":"Dimitriadis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Tsioufis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kasiakogias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Miliou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Poulakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Kintis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Bafakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Benardis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Tousoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Stefanadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2011.10.003_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3132\/dvdr.2009.002","article-title":"Receptor for advanced glycation end-product (RAGE) and soluble RAGE (sRAGE): cardiovascular implications","volume":"6","author":"Lindsey","year":"2009","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.numecd.2011.10.003_bib2","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1189\/jlb.1206751","article-title":"Receptor for advanced glycation end products (RAGE) in a dash to rescue: inflammatory signals gone awry in the primal response to stress","volume":"82","author":"Herold","year":"2007","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.numecd.2011.10.003_bib3","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1161\/01.CIR.0000039325.03698.36","article-title":"RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice","volume":"106","author":"Bucciarelli","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2011.10.003_bib4","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/2012","article-title":"Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation end products","volume":"4","author":"Park","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.numecd.2011.10.003_bib5","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.2741\/3315","article-title":"RAGE signaling in inflammation and arterial aging","volume":"14","author":"Lin","year":"2009","journal-title":"Front Biosci"},{"key":"10.1016\/j.numecd.2011.10.003_bib6","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1161\/01.ATV.0000190660.32863.cd","article-title":"Plasma levels of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis","volume":"25","author":"Koyama","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2011.10.003_bib7","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.2337\/diacare.28.11.2716","article-title":"Decreased endogenous secretory advanced glycation end products receptor in type 1 diabetic patients: its possible association with diabetic vascular complications","volume":"28","author":"Katakami","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2011.10.003_bib8","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1097\/01.hjh.0000177535.45785.64","article-title":"Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension","volume":"9","author":"Geroldi","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2011.10.003_bib9","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1161\/01.ATV.0000160342.20342.00","article-title":"Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men","volume":"25","author":"Falcone","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.numecd.2011.10.003_bib10","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00125-009-1263-5","volume":"52","author":"Nin","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.numecd.2011.10.003_bib11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/01.ATV.0000251502.88818.4b","article-title":"Low circulating endogenous secretory receptor for AGE\u2019s predicts cardiovascular mortality in patients with end-stage renal disease","volume":"27","author":"Koyama","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.numecd.2011.10.003_bib12","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3132\/dvdr.2008.031","article-title":"Endogenous secretory RAGE but not soluble RAGE is associated with carotid atherosclerosis in type 1 diabetes patients","volume":"5","author":"Katakami","year":"2008","journal-title":"Diab Vasc Dis Res"},{"issue":"12","key":"10.1016\/j.numecd.2011.10.003_bib13","first-page":"1065","article-title":"Advanced glycation end-products: implications for diabetic and non-diabetic nephropathies","volume":"39","author":"Daroux","year":"2009","journal-title":"Eur J Clin Invest"},{"issue":"11","key":"10.1016\/j.numecd.2011.10.003_bib14","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.metabol.2009.05.018","article-title":"Positive association of serum levels of advanced glycation end products and high mobility group box-1 with asymmetric dimethylarginine in nondiabetic chronic kidney disease patients","volume":"58","author":"Nakamura","year":"2009","journal-title":"Metabolism"},{"key":"10.1016\/j.numecd.2011.10.003_bib15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/117727190700200021","article-title":"Endogenous secretory RAGE as a Novel Biomarker for metabolic syndrome and cardiovascular diseases","volume":"2","author":"Koyama","year":"2007","journal-title":"Biomark Insights"},{"issue":"6","key":"10.1016\/j.numecd.2011.10.003_bib16","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1053\/j.ajkd.2009.11.024","article-title":"ADMA, C-reactive protein, and albuminuria in untreated essential hypertension: a cross-sectional study","volume":"55","author":"Tsioufis","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.numecd.2011.10.003_bib17","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/ajh.2010.34","article-title":"Association of resistin with urinary albumin excretion in nondiabetic patients with essential hypertension","volume":"23","author":"Tsioufis","year":"2010","journal-title":"Am J Hypertens"},{"issue":"6","key":"10.1016\/j.numecd.2011.10.003_bib18","first-page":"361","article-title":"The emerging role of subclinical inflammation in hypertension-associated early renal dysfunction: focus on microalbuminuria","volume":"47","author":"Tsioufis","year":"2006","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.numecd.2011.10.003_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1475-2840-6-9","article-title":"Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes","volume":"6","author":"Humpert","year":"2007","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"10.1016\/j.numecd.2011.10.003_bib20","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.2337\/dc05-2478","article-title":"Plasma sRAGE is independently associated with urinary albumin excretion in type 2 diabetes","volume":"29","author":"Humpert","year":"2006","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.numecd.2011.10.003_bib21","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijcard.2007.10.047","article-title":"Association between endogenous secretory RAGE, inflammatory markers and arterial stiffness","volume":"132","author":"Choi","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.numecd.2011.10.003_bib22","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1161\/01.HYP.37.5.1236","article-title":"Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients","volume":"37","author":"Laurent","year":"2001","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.numecd.2011.10.003_bib23","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","article-title":"The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"25","author":"Guidelines for the Management of Arterial Hypertension","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2011.10.003_bib24","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/sj.jhh.1001115","article-title":"Absence of any significant effects of circadian blood pressure variations on carotid artery elastic properties in essential hypertensive subjects","volume":"14","author":"Tsioufis","year":"2000","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.numecd.2011.10.003_bib25","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification","volume":"39","author":"National Kidney Foundation","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.numecd.2011.10.003_bib26","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0894-7317(89)80014-8","article-title":"Recommendations for quantitation of the left ventricular dimensions by two-dimensional echocardiography. American Society of Echocardiography Committee on standards, subcommittee on quantitation of the two-dimensional echocardiograms","volume":"2","author":"Schiller","year":"1989","journal-title":"J Am Soc Echocardiogr"},{"issue":"9","key":"10.1016\/j.numecd.2011.10.003_bib27","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/eurheartj\/ehm089","article-title":"Low-grade inflammation and hypoadiponectinaemia have an additive detrimental effect on aortic stiffness in essential hypertensive patients","volume":"28","author":"Tsioufis","year":"2007","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.numecd.2011.10.003_bib28","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/HJH.0b013e328344da49","article-title":"Combined effects of office and 24-h blood pressure on aortic stiffness in human hypertension","volume":"29","author":"Schillaci","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2011.10.003_bib29","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.metabol.2008.10.020","article-title":"Independent determinants of soluble forms of receptor for advanced glycation end products in elderly hypertensive patients","volume":"58","author":"Nakamura","year":"2009","journal-title":"Metabolism"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475311002377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475311002377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T01:20:45Z","timestamp":1640308845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475311002377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0939475311002377"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2011.10.003","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}